ALEXANDRIA, Va., March 31 -- United States Patent no. 12,592,370, issued on March 31, was assigned to Imperial College Innovations Ltd. (London).

"Screening with mass spectrometry for mycobacteria prior to cardiothoracic surgery" was invented by Gerald Larrouy-Maumus (London) and Francis Drobniewski (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a method for identifying a subject suitable for receiving a lung transplant, the method comprising: subjecting a sample to mass spectrometry analysis (in the negative ion mode or positive ion mode; preferably in the positive ion mode) and generating a mass spectrum output; wherein said sample is an isolated sample obtained from a subjec...